Alexis Zambrano-Zambrano
Research Subjects
Alexis Zambrano-Zambrano has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Ezquerra-Osorio
Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
1 shared publication - Axel Rodriguez-Méndez
Cardiac Intensive Care Unit, National Institute of Cardiology, Mexico City, MEX
1 shared publication - Efrén Melano-Carranza
Cardiac Intensive Care Unit, National Institute of Cardiology, Mexico City, MEX
1 shared publication - Jorge Antonio Cervantes-Nieto
Cardiology, PEMEX Regional Hospital Salamanca, Salamanca, MEX
1 shared publication - Juan Alan Fuentes Mendoza
Cardiology, National Institute of Cardiology Ignacio Chavez, Mexico City, MEX
1 shared publication - Juan Andres Pimentel-Esparza
Petr Mexicanos PEMEX Reg Hosp Salamanca, Dept Internal Med, Salamanca, Mexico
1 shared publication
Latest Publications
- Open Access
- 6 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33449
Coronary Artery Disease in Systemic Lupus Erythematosus: What Do the Facts Say?
Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect any organ with a predisposition for women of reproductive age. It is related to a higher risk of cardiovascular events, increasing it up to 50 times in young people, and 30% of deaths are attributed to coronary artery disease. The risk of developing cardiovascular disease in SLE is related not only to traditional cardiovascular risks factors such as advanced age, hypertension, dyslipidemia, and diabetes but also to disease-specific factors, such as degree of activity, autoantibodies, organ damage, and treatment. Accelerated atherosclerosis is one of the main contributors to pathogenesis. Manifestations range from angina to acute myocardial infarction and sudden death. Markers have been studied for the detection of subclinical disease and stratification of these patients, as well as different treatment options to improve the cardiovascular prognosis of the disease.
- 6 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33449
Open AccessCoronary Artery Disease in Systemic Lupus Erythematosus: What Do the Facts Say?
Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect any organ with a predisposition for women of reproductive age. It is related to a higher risk of cardiovascular events, increasing it up to 50 times in young people, and 30% of deaths are attributed to coronary artery disease. The risk of developing cardiovascular disease in SLE is related not only to traditional cardiovascular risks factors such as advanced age, hypertension, dyslipidemia, and diabetes but also to disease-specific factors, such as degree of activity, autoantibodies, organ damage, and treatment. Accelerated atherosclerosis is one of the main contributors to pathogenesis. Manifestations range from angina to acute myocardial infarction and sudden death. Markers have been studied for the detection of subclinical disease and stratification of these patients, as well as different treatment options to improve the cardiovascular prognosis of the disease.